Inhibiting BDNF expression by antisense oligonucleotide infusion causes loss of nigral dopaminergic neurons

作者: M.J. Porritt , P.E. Batchelor , D.W Howells

DOI: 10.1016/J.EXPNEUROL.2004.11.030

关键词:

摘要: Brain derived neurotrophic factor (BDNF) expression is significantly reduced in the Parkinson's disease substantia nigra. This neurotrophin has potent affects on dopaminergic neuron survival protecting them from neurotoxins MPTP and 6-hydroxydopamine (6-OHDA) commonly used to create animal models of also promoting axonal sprouting. In this study, we demonstrate that an antisense oligonucleotide infusion (200 nM for 28 days) prevent BDNF production nigra rats mimics many features classical disease. 62% treated rotate (P < or = 0.05) response receptor stimulation by apomorphine. 40% pars compacta tyrosine hydroxylase immunoreactive neurons are lost 0.00001) dopamine uptake site density measured (3)H-mazindol autoradiography 34% 0.005). Loss haematoxylin eosin stained nigral significant 0.0001) but less extensive (34%). These observations indicate loss leads both down regulation phenotype neuronal death. Therefore, mRNA may contribute directly death development

参考文章(55)
J Mokrý, Experimental models and behavioural tests used in the study of Parkinson's disease. Physiological Research. ,vol. 44, pp. 143- 150 ,(1995)
Yuen-Sum Lau, Ruyi Hao, Yiu K. Fung, Liu-Song Fu, John F. Bishop, Ronald F. Pfeiffer, M. Maral Mouradian, Modulation of nigrostriatal dopaminergic transmission by antisense oligodeoxynucleotide against brain-derived neurotrophic factor Neurochemical Research. ,vol. 23, pp. 525- 532 ,(1998) , 10.1023/A:1022482518292
D A Brown, S H Kang, S M Gryaznov, L DeDionisio, O Heidenreich, S Sullivan, X Xu, M I Nerenberg, Effect of phosphorothioate modification of oligodeoxynucleotides on specific protein binding. Journal of Biological Chemistry. ,vol. 269, pp. 26801- 26805 ,(1994) , 10.1016/S0021-9258(18)47090-1
Amelia J Eisch, Carlos A Bolaños, Joris de Wit, Ryan D Simonak, Cindy M Pudiak, Michel Barrot, Joost Verhaagen, Eric J Nestler, Brain-derived neurotrophic factor in the ventral midbrain-nucleus accumbens pathway: a role in depression. Biological Psychiatry. ,vol. 54, pp. 994- 1005 ,(2003) , 10.1016/J.BIOPSYCH.2003.08.003
L. Whitesell, D. Geselowitz, C. Chavany, B. Fahmy, S. Walbridge, J. R. Alger, L. M. Neckers, Stability, clearance, and disposition of intraventricularly administered oligodeoxynucleotides: implications for therapeutic application within the central nervous system. Proceedings of the National Academy of Sciences of the United States of America. ,vol. 90, pp. 4665- 4669 ,(1993) , 10.1073/PNAS.90.10.4665
C.Anthony Altar, Peter S DiStefano, Neurotrophin trafficking by anterograde transport Trends in Neurosciences. ,vol. 21, pp. 433- 437 ,(1998) , 10.1016/S0166-2236(98)01273-9
C.Anthony Altar, Carolyn B. Boylan, Michelle Fritsche, Carl Jackson, Carolyn Hyman, Ronald M. Lindsay, The Neurotrophins NT-4/5 and BDNF Augment Serotonin, Dopamine, and GABAergic Systems during Behaviorally Effective Infusions to the Substantia Nigra Experimental Neurology. ,vol. 130, pp. 31- 40 ,(1994) , 10.1006/EXNR.1994.1182
Mary J. Eaton, Julie K. Staley, Mordecai Y.-T. Globus, Scott R. Whittemore, Developmental Regulation of Early Serotonergic Neuronal Differentiation: The Role of Brain-Derived Neurotrophic Factor and Membrane Depolarization Developmental Biology. ,vol. 170, pp. 169- 182 ,(1995) , 10.1006/DBIO.1995.1205
Tetsuya Tsukahara, Makoto Takeda, Shun Shimohama, Osamu Ohara, Nobuo Hashimoto, Effects of brain-derived neurotrophic factor on 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced parkinsonism in monkeys. Neurosurgery. ,vol. 37, pp. 733- 741 ,(1995) , 10.1227/00006123-199510000-00018